One such investigation is the immunoscore, which refers to the density of two different lymphocyte populations (CD3+, CD8+ or CD45RO+ cells) quantified in the tumour core and the invasive margin, which was first shown to correlate with outcome in colorectal cancer (CRC) [4]. This evidence concerns the gene CD8A and neoplasm.